Originally called Mesynthes, Aroa Biosurgery has seen rapid growth over the last year or two, doubling revenue and now considering an IPO exit. Aroa develops and manufactures a special fabric from sheep rumen that is biocompatible. The product is used in wound care and surgical implant products. It is manufactured in a cleanroom in South Auckland and mostly exported overseas to the US and Europe.
The company was originally formed in 2008, and like many biotech companies it has taken a little bit of time to find success, but Aroa is now profitable and has dreams to grow even more, with new manufacturing facilities and products in the pipeline. The story also highlights the importance of partners, who can help fund research and development work along the way.